IL HR0659

Declares May 14, 2026 as IgAN Awareness Day in Illinois to increase awareness of IgA nephropathy and other kidney diseases among patients, providers, and policymakers

IgA nephropathy (IgAN) is the third-leading cause of kidney disease, with patients progressing to end-stage renal disease more quickly than typical chronic kidney disease patients

Rare kidney diseases comprise 5-10% of chronic kidney disease patients but account for approximately 25% of patients receiving kidney failure treatment

IgAN is twice as likely to occur in men, typically affects people in their twenties and thirties, and patients with IgAN-attributed end-stage renal disease have health costs exceeding $63,000 per year

More than 1 in 7 American adults have chronic kidney disease, yet up to 9 in 10 are unaware of their condition, highlighting the need for broader screening and early identification